KoKo and EirMed Announce Joint Manufacturing Partnership

KoKo, a developer of respiratory information systems software and medical devices, and EirMed today announced a joint manufacturing partnership.

The partnership for KoKo and EirMed will streamline the manufacturing of respiratory medical devices deployed globally by medical professionals in the delivery of unparalleled patient care.

The direct connection between KoKo’s respiratory medical devices and EirMed’s experience and knowledge enables the development and manufacturing of these devices and components. The partnership allows quick optimization of engineering, manufacturing, assembly, and packaging through rapid cycles.

“It is my pleasure to announce that KoKo medical devices and components can now be optimally manufactured, bringing them to market faster and under the highest quality standards. EirMed’s facilities and technologies provide a tailored method for innovative design and optimum manufacturing of our products,” said John Peterson, President, and CEO of KoKo.

“KoKo’s pulmonary technology advocates open and connected systems to manage and improve patient care. This partnership streamlines the overall process of product development in the respiratory medical device industry,” said Rick Curtis, President of EirMed.

The devices, designed and developed by KoKo and manufactured by EirMed, will soon be available to enhance patient care in pulmonary testing.

SourceKoKo

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”